SE8904407L - Medikament foer behandling av hjaertsvikt - Google Patents

Medikament foer behandling av hjaertsvikt

Info

Publication number
SE8904407L
SE8904407L SE8904407A SE8904407A SE8904407L SE 8904407 L SE8904407 L SE 8904407L SE 8904407 A SE8904407 A SE 8904407A SE 8904407 A SE8904407 A SE 8904407A SE 8904407 L SE8904407 L SE 8904407L
Authority
SE
Sweden
Prior art keywords
heart failure
medication
treatment
anp
inhibitors
Prior art date
Application number
SE8904407A
Other languages
English (en)
Other versions
SE8904407D0 (sv
Inventor
Qingpingfeng
Thomashedner
Original Assignee
Qingpingfeng
Thomashedner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingpingfeng, Thomashedner filed Critical Qingpingfeng
Priority to SE8904407A priority Critical patent/SE8904407L/sv
Publication of SE8904407D0 publication Critical patent/SE8904407D0/sv
Priority to EP91902229A priority patent/EP0510052A1/en
Priority to PCT/SE1990/000886 priority patent/WO1991009627A1/en
Priority to JP91502498A priority patent/JPH05506640A/ja
Publication of SE8904407L publication Critical patent/SE8904407L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8904407A 1989-12-29 1989-12-29 Medikament foer behandling av hjaertsvikt SE8904407L (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE8904407A SE8904407L (sv) 1989-12-29 1989-12-29 Medikament foer behandling av hjaertsvikt
EP91902229A EP0510052A1 (en) 1989-12-29 1990-12-28 Medicament for treatment of heart failure
PCT/SE1990/000886 WO1991009627A1 (en) 1989-12-29 1990-12-28 Medicament for treatment of heart failure
JP91502498A JPH05506640A (ja) 1989-12-29 1990-12-28 心不全治療用医薬

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8904407A SE8904407L (sv) 1989-12-29 1989-12-29 Medikament foer behandling av hjaertsvikt

Publications (2)

Publication Number Publication Date
SE8904407D0 SE8904407D0 (sv) 1989-12-29
SE8904407L true SE8904407L (sv) 1991-06-30

Family

ID=20377906

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8904407A SE8904407L (sv) 1989-12-29 1989-12-29 Medikament foer behandling av hjaertsvikt

Country Status (4)

Country Link
EP (1) EP0510052A1 (sv)
JP (1) JPH05506640A (sv)
SE (1) SE8904407L (sv)
WO (1) WO1991009627A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028055A (en) * 1996-10-22 2000-02-22 Genetech, Inc. Receptor selective BNP
US7632647B2 (en) 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US7524635B2 (en) 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
US6461828B1 (en) 2001-09-04 2002-10-08 Syn X Pharma Conjunctive analysis of biological marker expression for diagnosing organ failure
MXPA03004105A (es) 2002-05-14 2004-10-15 Hoffmann La Roche Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores.
SG159387A1 (en) 2002-11-26 2010-03-30 Biocon Ltd In Modified natriuretic compounds, conjugates, and uses thereof

Also Published As

Publication number Publication date
WO1991009627A1 (en) 1991-07-11
JPH05506640A (ja) 1993-09-30
EP0510052A1 (en) 1992-10-28
SE8904407D0 (sv) 1989-12-29

Similar Documents

Publication Publication Date Title
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE58904179D1 (de) Septum fuer implantierbare vorrichtungen zur abgabe von wirkstoffen.
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
DE3750619D1 (de) System zur Abgabe von Arzneistoffen.
DE68910867D1 (de) Matrix für die transdermale Abgabe von Arzneimitteln.
ES2177780T3 (es) Medicamentos para el tratamiento de enfermedades autoinmunes usando interferon tau.
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
DE3681570D1 (de) Medizinische einrichtung zur pulsatilen transdermalen verabreichung von biologisch aktiven wirkstoffen.
ATE85214T1 (de) Verzoegerte abgabe von makromolekularen polypeptiden.
DK618186D0 (da) Konfektureindgiftssystem til aktive stoffer
DE3586713D1 (de) Vorrichtung zur kontrollierten abgabe von arzneimittelwirkstoffen.
NO883918D0 (no) Beleggsformulering for bioaktive stoffer med kontrollert utloesning.
DE59006461D1 (de) Therapeutisches System zur verzögerten und gesteuerten transdermalen oder transmucosalen Verabreichung von Wirkstoffen (II).
BR9106977A (pt) Metodo para suprimir destruicao autoimune de celuias beta pancreaticas,formulacao farmaceutica,metodo de profilaxia,metodo para prevenir o surgimento de diabetes tipo 1 e metodo para tratar um mamifero
DE69533112T2 (de) Verwendung von flavolignanen zur herstellung von medikamenten mit antiproliferativer aktivität in gebärmutter,brust,eierstöcken
NO990916D0 (no) Bruk av GLP-1 eller analoger i behandlingen av myokardialt infarkt
IT8520242A0 (it) Polipeptide umano fisiologicamente attivo.
NO882897D0 (no) Avleveringssystem for legemidler.
FI845132A7 (sv) System för avgivande av aktiva substanser.
FI95653C (sv) Förfarande för framställning av en administrerings- och/eller doseringsform av ett läkemedel
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
ZA87472B (en) System for delivering drug with enhanced bioacceptability
DE69839423D1 (de) Verfahren zur prevention von gastritis unter verwendung von amylin oder amylin agonisten
DK79889A (da) Flerlagsplaster til transdermal laegemiddeladministration
SE8904407D0 (sv) Medikament foer behandling av hjaertsvikt

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8904407-7

Effective date: 19930701